Securian Asset Management, Inc Biogen Inc. Transaction History

Securian Asset Management, Inc

$3.4 Billion
Q2 2024

A detailed history of Securian Asset Management, Inc transactions in Biogen Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 8,296 shares of BIIB stock, worth $1.44 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,296

Previous 8,496 2.35%

Holding current value

$1.44 Million

Previous $1.83 Million 5.02%

% of portfolio

0.06%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$190.52 - $236.72 $38,104 - $47,344	-200 Reduced 2.35%	8,296 $1.92 Million
Q1 2024 Apr 26, 2024	SELL	$212.02 - $267.71 $144,809 - $182,845	-683 Reduced 7.44%	8,496 $1.83 Million
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $267,330 - $321,795	-1,201 Reduced 11.57%	9,179 $2.38 Million
Q3 2023 Oct 30, 2023	SELL	$253.3 - $285.89 $433,902 - $489,729	-1,713 Reduced 14.17%	10,380 $2.67 Million
Q1 2023 Apr 27, 2023	BUY	$256.56 - $292.34 $25,656 - $29,233	100 Added 0.83%	12,093 $3.36 Million
Q4 2022 Feb 02, 2023	BUY	$252.44 - $306.72 $45,944 - $55,823	182 Added 1.54%	11,993 $3.32 Million
Q3 2022 Oct 28, 2022	SELL	$194.69 - $268.46 $19,469 - $26,845	-100 Reduced 0.84%	11,811 $3.15 Million
Q1 2022 May 03, 2022	SELL	$193.77 - $244.14 $38,754 - $48,828	-200 Reduced 1.65%	11,911 $2.51 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $139,502 - $179,280	-623 Reduced 4.89%	12,111 $2.91 Million
Q3 2021 Nov 08, 2021	SELL	$282.99 - $369.05 $71,313 - $93,000	-252 Reduced 1.94%	12,734 $3.6 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $70,966 - $113,630	-274 Reduced 2.07%	12,986 $4.5 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $122,446 - $143,453	-504 Reduced 3.66%	13,260 $3.71 Million
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $159,711 - $240,405	-676 Reduced 4.68%	13,764 $3.37 Million
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $149,859 - $173,031	-566 Reduced 3.77%	14,440 $4.1 Million
Q2 2020 Aug 06, 2020	SELL	$258.66 - $342.55 $707,693 - $937,216	-2,736 Reduced 15.42%	15,006 $4.02 Million
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $71,514 - $90,716	-266 Reduced 1.48%	17,742 $5.61 Million
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $247,127 - $341,470	-1,123 Reduced 5.87%	18,008 $5.34 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $267,886 - $300,460	-1,232 Reduced 6.05%	19,131 $4.45 Million
Q2 2019 Aug 05, 2019	SELL	$219.29 - $241.72 $21,929 - $24,172	-100 Reduced 0.49%	20,363 $4.76 Million
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $53,744 - $84,062	-248 Reduced 1.2%	20,463 $4.84 Million
Q4 2018 Feb 04, 2019	BUY	$278.5 - $352.75 $4,734 - $5,996	17 Added 0.08%	20,711 $6.23 Million
Q3 2018 Oct 26, 2018	SELL	$293.51 - $383.83 $295,271 - $386,132	-1,006 Reduced 4.64%	20,694 $7.31 Million
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $25,752 - $30,691	100 Added 0.46%	21,700 $6.3 Million
Q1 2018 Apr 30, 2018	SELL	$260.13 - $367.91 $26,013 - $36,791	-100 Reduced 0.46%	21,600 $5.92 Million
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $36,916 - $41,349	120 Added 0.56%	21,700 $6.91 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $5,060 - $5,934	18 Added 0.08%	21,580 $6.76 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,562	21,562 $5.85 Million

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Biogen Inc. Transaction History